Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Fanelli

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|June 23, 2025
Insulin resistance and poorer treatment outcomes in depression: evidence from UK Biobank primary care dataGiuseppe Fanelli, Janita Bralten, Barbara Franke, et al.
Nutrients|March 28, 2024
Nutritional Management of Athletes with Type 1 Diabetes: A Narrative ReviewMassimiliano Cavallo, Michelantonio De Fano, Luisa Barana, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 12, 2020
Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorderGiuseppe Fanelli, Francesco Benedetti, Siegfried Kasper, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 2, 2026
Educational Attainment Polygenic Scores and School Performance in Adolescents With Psychiatric Disorders: A Population-Based Analysis of 86,122 Individuals From the iPSYCH2015 Case-CohortGiuseppe Fanelli, Hannah Chatwin, Katrine Holde, et al.
International Clinical Psychopharmacology|December 2, 2024
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?Gianluca Borgiani, Chiara Possidente, Chiara Fabbri, et al.
International Journal of Psychiatry in Clinical Practice|September 28, 2024
Mirtazapine blood levels and antidepressant responseDomenico De Donatis, Marco Verrastro, Giuseppe Fanelli, et al.
Psychological Medicine|May 22, 2025
Shared genetics and causal relationship between sociability and the brain's default mode networkGiuseppe Fanelli, Jamie Robinson, Chiara Fabbri, et al.
Journal of Affective Disorders|June 12, 2022
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAsGernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
Journal of Affective Disorders|March 4, 2019
Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depressionGiuseppe Fanelli, Francesco Benedetti, Sheng-Min Wang, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 22, 2019
Reduced plasma Fetuin-A is a promising biomarker of depression in the elderlyGiuseppe Fanelli, Francesco Benedetti, Sheng-Min Wang, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
The British Journal of Psychiatry : the Journal of Mental Science|June 23, 2025
Insulin resistance and poorer treatment outcomes in depression: evidence from UK Biobank primary care dataGiuseppe Fanelli, Janita Bralten, Barbara Franke, et al.
Nutrients|March 28, 2024
Nutritional Management of Athletes with Type 1 Diabetes: A Narrative ReviewMassimiliano Cavallo, Michelantonio De Fano, Luisa Barana, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 12, 2020
Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorderGiuseppe Fanelli, Francesco Benedetti, Siegfried Kasper, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 2, 2026
Educational Attainment Polygenic Scores and School Performance in Adolescents With Psychiatric Disorders: A Population-Based Analysis of 86,122 Individuals From the iPSYCH2015 Case-CohortGiuseppe Fanelli, Hannah Chatwin, Katrine Holde, et al.
International Clinical Psychopharmacology|December 2, 2024
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?Gianluca Borgiani, Chiara Possidente, Chiara Fabbri, et al.
International Journal of Psychiatry in Clinical Practice|September 28, 2024
Mirtazapine blood levels and antidepressant responseDomenico De Donatis, Marco Verrastro, Giuseppe Fanelli, et al.
Psychological Medicine|May 22, 2025
Shared genetics and causal relationship between sociability and the brain's default mode networkGiuseppe Fanelli, Jamie Robinson, Chiara Fabbri, et al.
Journal of Affective Disorders|June 12, 2022
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAsGernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
Journal of Affective Disorders|March 4, 2019
Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depressionGiuseppe Fanelli, Francesco Benedetti, Sheng-Min Wang, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 22, 2019
Reduced plasma Fetuin-A is a promising biomarker of depression in the elderlyGiuseppe Fanelli, Francesco Benedetti, Sheng-Min Wang, et al.
Pageof 9